Gefitinib Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Gefitinib Gefitinib EP Impurity B VE008983View CAS 1603814-04-5
Gefitinib Gefitinib Impurity 10 VL4010005View CAS 230955-75-6
Gefitinib Gefitinib Impurity 12 VL4010007View CAS 184475-71-6
Gefitinib Gefitinib Impurity 2 VL4010006View CAS 675126-26-8
Gefitinib Gefitinib Impurity 4 VL4010004View CAS 179688-52-9
Gefitinib Gefitinib Impurity III VL4010001View CAS 95-76-1
Gefitinib Gefitinib Impurity V VL4010002View CAS 367-21-5
Gefitinib Gefitinib N-Oxide VE0012000View CAS 847949-51-3
Gefitinib Gefitinib impurity VI VL4010003View CAS 7357-67-7
Gefitinib 4-(3-((4-Chloro-7-methoxyquinazolin-6-yl]oxy]propyl)morpholine VE0012004View CAS 199327-59-8
Gefitinib 6,7-Dimethoxyquinazoline-4-one VL4010008View CAS 13794-72-4

Request a quote

13794-72-4: 6,7-Dimethoxyquinazoline-4-one

13794-72-4: 6,7-Dimethoxyquinazoline-4-one
Catalogue No.

VL4010008
CAS No.

13794-72-4
Molecular Formula

C₁₀H₁₀N₂O₃
Molecular Weight

206.2
Parent drug

Gefitinib
IUPAC Name

6, 7-Dimethoxy-3, 4-dihydroquinazolin-4-one
References

Kumar, Neeraj, et al. “A Simple and Highly Efficient Process for Synthesis of Gefitinib and Its Intermediate.” Indian Journal of Chemistry, vol. 53, 2014, pp. 1269–74, nopr.niscair.res.in/bitstream/123456789/29472/1/IJCB53B101269-1274.pdf.
Status

In-stock
ListName

6,7-Dimethoxyquinazoline-4-one
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url